# FDA Inspection 1100373 - Amarin Pharma Inc. - August 02, 2019

Source: https://www.keypedia.com/records/fda_inspections/amarin-pharma-inc/58d0bbde-fcdf-427f-9577-b5c13653b8f2
Source feed: FDA_Inspections

> FDA Inspection 1100373 for Amarin Pharma Inc. on August 02, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1100373
- Company Name: Amarin Pharma Inc.
- Inspection Date: 2019-08-02
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 891859 - 2014-09-09](https://www.keypedia.com/records/fda_inspections/amarin-pharma-inc/c337313d-d9e6-4330-adeb-c63f6f86af67)
- [FDA Inspection 891859 - 2014-09-09](https://www.keypedia.com/records/fda_inspections/amarin-pharma-inc/8a08dd4d-4c66-4a37-a791-bc29913e465c)
- [FDA Inspection 854226 - 2013-10-29](https://www.keypedia.com/records/fda_inspections/amarin-pharma-inc/e85de40f-0429-4f03-88fe-46b4914954cb)

Company: https://www.keypedia.com/companies/amarin-pharma-inc/dd301a42-2e08-4db9-929f-eaf4891ffad7

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c